186 related articles for article (PubMed ID: 35417751)
1. Maternal Herpesviridae infection during pregnancy alters midbrain dopaminergic signatures in adult offspring.
Burmeister AR; Gordevicius J; Paul EN; Houck C; George S; Escobar Galvis ML; Sha Q; Brundin P; Pospisilik JA; Racicot K; Brundin L
Neurobiol Dis; 2022 Jul; 169():105720. PubMed ID: 35417751
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
Pinto M; Nissanka N; Peralta S; Brambilla R; Diaz F; Moraes CT
Mol Neurodegener; 2016 Apr; 11():25. PubMed ID: 27038906
[TBL] [Abstract][Full Text] [Related]
3. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Dopaminergic Functions in Drosophila.
Inoshita T; Takemoto D; Imai Y
Methods Mol Biol; 2021; 2322():185-193. PubMed ID: 34043204
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.
Tozzi A; Tantucci M; Marchi S; Mazzocchetti P; Morari M; Pinton P; Mancini A; Calabresi P
Cell Death Dis; 2018 Feb; 9(2):204. PubMed ID: 29434188
[TBL] [Abstract][Full Text] [Related]
6. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
[TBL] [Abstract][Full Text] [Related]
7. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
Smajić S; Prada-Medina CA; Landoulsi Z; Ghelfi J; Delcambre S; Dietrich C; Jarazo J; Henck J; Balachandran S; Pachchek S; Morris CM; Antony P; Timmermann B; Sauer S; Pereira SL; Schwamborn JC; May P; Grünewald A; Spielmann M
Brain; 2022 Apr; 145(3):964-978. PubMed ID: 34919646
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
[TBL] [Abstract][Full Text] [Related]
10. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
13. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
[TBL] [Abstract][Full Text] [Related]
14. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
15. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
[TBL] [Abstract][Full Text] [Related]
16. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
17. Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
Bifsha P; Balsalobre A; Drouin J
Mol Neurobiol; 2017 Sep; 54(7):4921-4935. PubMed ID: 27514757
[TBL] [Abstract][Full Text] [Related]
18. Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
Reyes S; Cottam V; Kirik D; Double KL; Halliday GM
Mov Disord; 2013 Sep; 28(10):1351-9. PubMed ID: 23674405
[TBL] [Abstract][Full Text] [Related]
19. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
20. Developmental Dieldrin Exposure Alters DNA Methylation at Genes Related to Dopaminergic Neuron Development and Parkinson's Disease in Mouse Midbrain.
Kochmanski J; VanOeveren SE; Patterson JR; Bernstein AI
Toxicol Sci; 2019 Jun; 169(2):593-607. PubMed ID: 30859219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
